Correlation Between Icosavax and Alpine Immune

Can any of the company-specific risk be diversified away by investing in both Icosavax and Alpine Immune at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Icosavax and Alpine Immune into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Icosavax and Alpine Immune Sciences, you can compare the effects of market volatilities on Icosavax and Alpine Immune and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Icosavax with a short position of Alpine Immune. Check out your portfolio center. Please also check ongoing floating volatility patterns of Icosavax and Alpine Immune.

Diversification Opportunities for Icosavax and Alpine Immune

0.85

Correlation Coefficient

Icosavax  Alpine Immune

Very poor diversification

The 3 months correlation between Icosavax and Alpine is 0.85. Overlapping area represents the amount of risk that can be diversified away by holding Icosavax and Alpine Immune Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alpine Immune Sciences and Icosavax is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Icosavax are associated (or correlated) with Alpine Immune. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alpine Immune Sciences has no effect on the direction of Icosavax i.e., Icosavax and Alpine Immune go up and down completely randomly.

Pair Corralation between Icosavax and Alpine Immune

If you would invest  1,237  in Alpine Immune Sciences on October 27, 2024 and sell it today you would earn a total of  0.00  from holding Alpine Immune Sciences or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

Icosavax  vs.  Alpine Immune Sciences

Icosavax

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Icosavax has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Icosavax is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Alpine Immune Sciences

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Alpine Immune Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Alpine Immune is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Icosavax and Alpine Immune

The main advantage of trading using opposite Icosavax and Alpine Immune positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Icosavax position performs unexpectedly, Alpine Immune can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alpine Immune will offset losses from the drop in Alpine Immune's long position.

The idea behind Icosavax and Alpine Immune Sciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.